Electrophysiology Clinical Research & Innovations
Cardiac arrhythmias, which are characterized as irregular heartbeats, can cause significant damage to a person’s heart over the short and long term. The mission of the Electrophysiology Clinical Research & Innovations department (ECRI) is to create and develop an infrastructure for translational and clinical cardiac arrhythmia research and innovation, and to be an internationally recognized leader in the field of cardiac arrhythmias research and management.
The team does this through a specific focus on translational research that will innovate devices and techniques used to detect, manage and treat various cardiac conditions, in particular arrhythmias. Led by Director Mehdi Razavi, MD, the team emphasizes the importance of innovations that will improve healthcare outcomes for hospitals as well as patient’s and their quality of life.
The ECRI’s current research studies include projects centered around the:
- Application of carbon nanotube fibers as a therapeutic and diagnostic tool to manage heart disease
- Development of a wireless, lead-less pacemaker to provide personalized multisite pacing therapies
- Creation of an impedance-based navigation tool to enable easier access to pericardial space during epicardial procedures
- Texas team debuts battery-less pacemaker
- Texas Heart Institute and Rice University receive American Heart Association Grant
- Nanotube fibers may restore electrical health to damaged hearts
Dr. Mehdi Razavi will be the special guest speaker at an upcoming WomenHeart Support Group Meeting in Houston. Learn more.